TLDR Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.
The 2020 study "The Association Between Polycystic Ovary Syndrome and Its Dermatological Manifestations" investigated the relationship between Polycystic Ovary Syndrome (PCOS) and skin conditions such as hirsutism, acne, seborrheic dermatitis, and androgenetic alopecia. The study found that women with PCOS were more likely to experience these dermatological issues, suggesting that these conditions could be potential indicators of PCOS. The relationship between PCOS and these skin conditions was found to be complex, involving factors such as inflammation, genetics, and hormonal imbalances. The study concluded that more research was needed to better understand these relationships and improve the management of PCOS. It also suggested the development of a questionnaire for early diagnosis of PCOS in women presenting with these symptoms.
Cited in this study
7 / 7 results
195 citations
,
March 2020 in “Clinica Chimica Acta” High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.
767 citations
,
September 2016 in “Human Reproduction” Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.
19 citations
,
January 2015 in “Indian Journal of Dermatology” Skin changes in women with PCOS are mainly due to hormonal imbalances.
16 citations
,
March 2014 in “Journal of the European Academy of Dermatology and Venereology” Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.
28 citations
,
December 2013 in “Journal of The American Academy of Dermatology” Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.
414 citations
,
August 2005 in “The Journal of Clinical Endocrinology and Metabolism” Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.
176 citations
,
January 2003 in “Journal of Investigative Dermatology” Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.
